Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)
Lithium
42.50
(2.03%)
Gold
2,678.90
0.58%
Copper
4.34
(1.41%)
Oil
70.94
(0.8%)
Bitcoin
66,623.16
0.85%
FTSE 100
8,249.28
(0.52%)
Nikkei 225
39,910.55
(0.34%)
Dow Jones
42,740.42
(1.16%)
Iron Ore
106.40
(1.11%)
USD/AUD
0.67
(0.36%)
Hang Seng
20,318.79
(3.46%)

OncoSil Medical (ASX:OSL) Results of Annual General Meeting

On 29 November 2023, OncoSil Medical Ltd, a medical device company focusing on localised treatments for patients with locally advanced pancreatic cancer (LAPC), held its Annual General Meeting (AGM) in Melbourne, Australia.

AGM Presentation Highlights

  1. Corporate Overview: OncoSil Medical, listed on ASX under the ticker $OSL since 15 August 2005, holds a market capitalization of $15.8 million with 1975.8 million shares issued. The share price stands fluctuates between a 52-week high of $0.041 and a low of $0.008​​
  2. OncoSil Device and Market Position: The OncoSil device, a commercial breakthrough in targeted radiotherapy for pancreatic cancer, has gained significant traction. It is approved for sale in 34 countries, with a large global addressable market, including a yearly global population of approximately 130,000 patients​​.
  3. Significant Accomplishments: OncoSil Medical has achieved key milestones, including CE Marking, US FDA breakthrough device designation, and successful completion of the PanCO Study, demonstrating the device’s safety and efficacy​​. 33% of patients treated with OncoSil became eligible for surgical resection, and 57% saw at least a 50% reduction in tumour volume​​.
  4. Commercialisation Progress: The early-stage commercialisation of the OncoSil device has already begun, with a focus on expanding the addressable market and securing innovation funding in Germany.

OncoSil Medical has made notable progress over the past year, marked by significant regulatory achievements and early commercial success. The company remains focused on expanding the market reach of its innovative OncoSil device and securing necessary funding to support further growth and development.


Author

  • James Turner

    James Turner is a skilled economist and fund manager with extensive experience in the investment sector. Known for his strategic thinking and analytical skills, James has played a key role in the success of many investment portfolios. In addition to his financial work, he writes about market trends and shares his insights through various publications.

    View all posts
0 Comments
Inline Feedbacks
View all comments
Social Media Auto Publish Powered By : XYZScripts.com

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions